240 related articles for article (PubMed ID: 37542170)
1. Tasmanian devil cathelicidins exhibit anticancer activity against Devil Facial Tumour Disease (DFTD) cells.
Petrohilos C; Patchett A; Hogg CJ; Belov K; Peel E
Sci Rep; 2023 Aug; 13(1):12698. PubMed ID: 37542170
[TBL] [Abstract][Full Text] [Related]
2. Cathelicidins in the Tasmanian devil (Sarcophilus harrisii).
Peel E; Cheng Y; Djordjevic JT; Fox S; Sorrell TC; Belov K
Sci Rep; 2016 Oct; 6():35019. PubMed ID: 27725697
[TBL] [Abstract][Full Text] [Related]
3. Curse of the devil: molecular insights into the emergence of transmissible cancers in the Tasmanian devil (Sarcophilus harrisii).
Patchett AL; Flies AS; Lyons AB; Woods GM
Cell Mol Life Sci; 2020 Jul; 77(13):2507-2525. PubMed ID: 31900624
[TBL] [Abstract][Full Text] [Related]
4. Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease.
Tovar C; Patchett AL; Kim V; Wilson R; Darby J; Lyons AB; Woods GM
PLoS One; 2018; 13(4):e0196469. PubMed ID: 29702669
[TBL] [Abstract][Full Text] [Related]
5. Devil Facial Tumor Disease.
Pye RJ; Woods GM; Kreiss A
Vet Pathol; 2016 Jul; 53(4):726-36. PubMed ID: 26657222
[TBL] [Abstract][Full Text] [Related]
6. The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell Lines.
Patchett AL; Darby JM; Tovar C; Lyons AB; Woods GM
PLoS One; 2016; 11(12):e0168068. PubMed ID: 27936237
[TBL] [Abstract][Full Text] [Related]
7. Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations.
Kreiss A; Brown GK; Tovar C; Lyons AB; Woods GM
Vaccine; 2015 Jun; 33(26):3016-25. PubMed ID: 25708088
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils.
Pye R; Hamede R; Siddle HV; Caldwell A; Knowles GW; Swift K; Kreiss A; Jones ME; Lyons AB; Woods GM
Biol Lett; 2016 Oct; 12(10):. PubMed ID: 28120799
[TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells.
Brown GK; Tovar C; Cooray AA; Kreiss A; Darby J; Murphy JM; Corcoran LM; Bettiol SS; Lyons AB; Woods GM
Immunol Cell Biol; 2016 Aug; 94(7):673-9. PubMed ID: 27089941
[TBL] [Abstract][Full Text] [Related]
10. Immunoglubolin dynamics and cancer prevalence in Tasmanian devils (Sarcophilus harrisii).
Ujvari B; Hamede R; Peck S; Pemberton D; Jones M; Belov K; Madsen T
Sci Rep; 2016 Apr; 6():25093. PubMed ID: 27126067
[TBL] [Abstract][Full Text] [Related]
11. Lessons learnt from the Tasmanian devil facial tumour regarding immune function in cancer.
Peel E; Belov K
Mamm Genome; 2018 Dec; 29(11-12):731-738. PubMed ID: 30225648
[TBL] [Abstract][Full Text] [Related]
12. Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils.
Tovar C; Pye RJ; Kreiss A; Cheng Y; Brown GK; Darby J; Malley RC; Siddle HV; Skjødt K; Kaufman J; Silva A; Baz Morelli A; Papenfuss AT; Corcoran LM; Murphy JM; Pearse MJ; Belov K; Lyons AB; Woods GM
Sci Rep; 2017 Mar; 7():43827. PubMed ID: 28276463
[TBL] [Abstract][Full Text] [Related]
13. Two of a kind: transmissible Schwann cell cancers in the endangered Tasmanian devil (Sarcophilus harrisii).
Patchett AL; Coorens THH; Darby J; Wilson R; McKay MJ; Kamath KS; Rubin A; Wakefield M; Mcintosh L; Mangiola S; Pye RJ; Flies AS; Corcoran LM; Lyons AB; Woods GM; Murchison EP; Papenfuss AT; Tovar C
Cell Mol Life Sci; 2020 May; 77(9):1847-1858. PubMed ID: 31375869
[TBL] [Abstract][Full Text] [Related]
14. Cathelicidin-3 Associated With Serum Extracellular Vesicles Enables Early Diagnosis of a Transmissible Cancer.
Espejo C; Wilson R; Pye RJ; Ratcliffe JC; Ruiz-Aravena M; Willms E; Wolfe BW; Hamede R; Hill AF; Jones ME; Woods GM; Lyons AB
Front Immunol; 2022; 13():858423. PubMed ID: 35422813
[TBL] [Abstract][Full Text] [Related]
15. Transmissible cancer influences immune gene expression in an endangered marsupial, the Tasmanian devil (Sarcophilus harrisii).
Raven N; Klaassen M; Madsen T; Thomas F; Hamede RK; Ujvari B
Mol Ecol; 2022 Apr; 31(8):2293-2311. PubMed ID: 35202488
[TBL] [Abstract][Full Text] [Related]
16. Sex determination by SRY PCR and sequencing of Tasmanian devil facial tumour cell lines reveals non-allograft transmission.
Cui X; Wang Y; Hua B; Miller W; Zhao Y; Cui H; Kong X
Biochem Biophys Res Commun; 2016 May; 474(1):29-34. PubMed ID: 27084454
[TBL] [Abstract][Full Text] [Related]
17. The immunohistochemical characterization of devil facial tumor disease (DFTD) in the Tasmanian Devil (Sarcophilus harrisii).
Loh R; Hayes D; Mahjoor A; O'Hara A; Pyecroft S; Raidal S
Vet Pathol; 2006 Nov; 43(6):896-903. PubMed ID: 17099146
[TBL] [Abstract][Full Text] [Related]
18. Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells from the Tasmanian Devil (
Weeratunga P; Shahsavari A; Fennis E; Wolvetang EJ; Ovchinnikov DA; Whitworth DJ
Stem Cells Dev; 2020 Jan; 29(1):25-37. PubMed ID: 31709909
[TBL] [Abstract][Full Text] [Related]
19. Cancer- and behavior-related genes are targeted by selection in the Tasmanian devil (Sarcophilus harrisii).
Hubert JN; Zerjal T; Hospital F
PLoS One; 2018; 13(8):e0201838. PubMed ID: 30102725
[TBL] [Abstract][Full Text] [Related]
20. Season, weight, and age, but not transmissible cancer, affect tick loads in the endangered Tasmanian devil.
Belkhir S; Hamede R; Thomas F; Ujvari B; Dujon AM
Infect Genet Evol; 2022 Mar; 98():105221. PubMed ID: 35065301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
